Form4insider filings, from the source

SEC Form 4 · accession 0001136261-16-000651

PERNIX THERAPEUTICS HOLDINGS, INC. · PTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John A Sedor
Officer — CHAIRMAN OF THE BOARD AND CEO · Director
Period of report
Nov 3, 2016
Accepted (ET)
Nov 7, 2016 · 5:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
COMMON STOCKF1Nov 3, 2016A131,100$0.00A131,100D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F2$3.15Nov 3, 2016A150,000A—Nov 2, 2026Common Stock150,000150,000D
Stock Option (right to buy)F3$3.36Nov 3, 2016A40,000A—Nov 2, 2026Common Stock40,00040,000D

Explanation of responses